Here, we demonstrate that the treatment of HUVECs with ANP did not promote proliferation or migration, nor did ANP treatment reduce markers of endothelial dysfunction in in vitro models of dysfunction. The gene discussed is NPPA; the disease is endothelial dysfunction.